Prime Medicine

PRME

Market cap $711M

3.94 USD

+0.02

0.51%

At close Updated Jan 9, 4:00 PM EST

Pre-market

After hours

4.00

+0.06

1.52%

1 day

0.51%

5 days

7.95%

1 month

-5.97%

3 months

-36.76%

6 months

-13.22%

Year to date

11.61%

1 year

34.01%

5 years

-74.37%

10 years

-74.37%

About: Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Employees: 214

Healthcare Biotechnology